Dialectical Behavior Therapy for Fetal Alcohol Spectrum Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether Dialectical Behavior Therapy for Adolescents (DBT-A) can assist teens with fetal alcohol spectrum disorders (FASD). It examines the perspectives of teens, caregivers, and therapists on the therapy, as well as its challenges and benefits. Suitable participants have FASD, reside in New York, and experience emotional or behavioral challenges, such as mood swings or relationship difficulties. The trial includes virtual therapy sessions for both teens and their caregivers. As an unphased trial, it provides a unique opportunity for participants to contribute to the understanding and enhancement of therapeutic approaches for FASD.
Do I need to stop my current medications for this trial?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this therapy is safe for adolescents with FASD?
Research has shown that Dialectical Behavior Therapy for Adolescents (DBT-A) is generally safe and well-received. This therapy has been adapted for various groups with different mental health conditions. No major safety concerns exist for using DBT-A with teens who have Fetal Alcohol Spectrum Disorders (FASD). DBT-A teaches skills like managing emotions and coping, which are non-invasive and don't require medication, resulting in a very low risk of negative effects. Although specific data on using this therapy for FASD is limited, the overall safety record of DBT-A remains reassuring.12345
Why are researchers excited about this trial?
Dialectical Behavior Therapy for Adolescents (DBT-A) is unique because it offers a tailored therapeutic approach specifically designed for teens with Fetal Alcohol Spectrum Disorders (FASD). Unlike standard treatments that often focus on medication or general behavioral strategies, DBT-A incorporates mindfulness, emotional regulation, distress tolerance, and interpersonal effectiveness skills, which are crucial for managing the complex emotional and behavioral challenges associated with FASD. Researchers are excited because DBT-A has the potential to directly address the underlying emotional dysregulation and improve overall functioning, offering a more holistic and personalized intervention compared to conventional approaches.
What evidence suggests that dialectical behavior therapy might be an effective treatment for fetal alcohol spectrum disorders?
Research has shown that Dialectical Behavior Therapy for Adolescents (DBT-A) can help young people with Fetal Alcohol Spectrum Disorders (FASD). Studies have found significant improvements in participants' suicidal thoughts, self-harm, emotional control, and depression. In this trial, researchers will administer DBT-A to a single cohort of teens with FASD to test its feasibility. This therapy aims to help teens with FASD manage their emotions better and reduce harmful behaviors. Evidence suggests that DBT-A could be a promising way to improve mental health in teens with FASD.13567
Are You a Good Fit for This Trial?
This trial is for adolescents with Fetal Alcohol Spectrum Disorders (FASD) and their caregivers. Participants will join an adapted Dialectical Behavior Therapy program designed for neurodivergent teens. The study aims to include two groups of five adolescents each.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive dialectical behavior therapy for adolescents (DBT-A) adapted for neurodivergent teens, including individual therapy, group skills training, and 24/7 phone coaching
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dialectical Behavior Therapy for Adolescents
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator